Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke
- 1 December 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 39 (12), 3372-3377
- https://doi.org/10.1161/strokeaha.108.514026
Abstract
Background and Purpose— Thrombolysis with tPA is the only FDA-approved therapy for acute ischemic stroke. But its widespread application remains limited by narrow treatment time windows and the related risks of cerebral hemorrhage. In this study, we ask whether minocycline can prevent tPA-associated cerebral hemorrhage and extend the reperfusion window in an experimental stroke model in rats. Methods— Spontaneously hypertensive rats were subjected to embolic focal ischemia using homologous clots and treated with: saline at 1 hour; early tPA at 1 hour, delayed tPA at 6 hours; minocycline at 4 hours; combined minocycline at 4 hours plus tPA at 6 hours. Infarct volumes and hemorrhagic transformation were quantified at 24 hours. Gelatin zymography was used to measure blood levels of circulating matrix metalloproteinase-9 (MMP-9). Results— Early 1-hour thrombolysis restored perfusion and reduced infarction. Late 6-hour tPA did not decrease infarction but instead worsened hemorrhagic conversion. Combining minocycline with delayed 6-hour tPA decreased plasma MMP-9 levels, reduced infarction, and ameliorated brain hemorrhage. Blood levels of MMP-9 were also significantly correlated with volumes of infarction and hemorrhage. Conclusion— Combination therapy with minocycline may extend tPA treatment time windows in ischemic stroke.Keywords
This publication has 40 references indexed in Scilit:
- Stromelysin‐1 (MMP‐3) is critical for intracranial bleeding after t‐PA treatment of stroke in miceJournal of Thrombosis and Haemostasis, 2007
- Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in RatJournal of Cerebral Blood Flow & Metabolism, 2006
- Dose–Response Effect of Tetracyclines on Cerebral Matrix Metalloproteinase-9 after Vascular Endothelial Growth Factor HyperstimulationJournal of Cerebral Blood Flow & Metabolism, 2006
- Neutrophil Infiltration Increases Matrix Metalloproteinase-9 in the Ischemic Brain after Occlusion/Reperfusion of the Middle Cerebral Artery in RatsJournal of Cerebral Blood Flow & Metabolism, 2003
- Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological DysfunctionNeurosurgery, 2001
- Reduction of Tissue Plasminogen Activator-Induced Hemorrhage and Brain Injury by Free Radical Spin Trapping after Embolic Focal Cerebral Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 2000
- Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic StrokeStroke, 1997
- Hemorrhagic Transformation in Acute Ischemic StrokeStroke, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Microvascular Basal Lamina Antigens Disappear During Cerebral Ischemia and ReperfusionStroke, 1995